Free Trial

DG Innovate (DGI) Competitors

GBX 0.07
+0.01 (+17.39%)
(As of 11/1/2024 ET)

DGI vs. STX, APC, STK, IDEA, ELX, GELN, DWHA, EAAS, PPS, and LPA

Should you be buying DG Innovate stock or one of its competitors? The main competitors of DG Innovate include Shield Therapeutics (STX), Apc Technology Group (APC), StreaksAI (STK), Ideagen (IDEA), El Oro (ELX), Gelion (GELN), Dewhurst Group (DWHA), eEnergy Group (EAAS), Proton Motor Power Systems (PPS), and LPA Group (LPA).

DG Innovate vs.

Shield Therapeutics (LON:STX) and DG Innovate (LON:DGI) are both small-cap medical companies, but which is the superior stock? We will compare the two companies based on the strength of their dividends, valuation, analyst recommendations, media sentiment, profitability, institutional ownership, earnings, community ranking and risk.

Shield Therapeutics received 215 more outperform votes than DG Innovate when rated by MarketBeat users.

CompanyUnderperformOutperform
Shield TherapeuticsOutperform Votes
215
75.17%
Underperform Votes
71
24.83%
DG InnovateN/AN/A

Shield Therapeutics has a beta of 1.42, suggesting that its stock price is 42% more volatile than the S&P 500. Comparatively, DG Innovate has a beta of 3.55, suggesting that its stock price is 255% more volatile than the S&P 500.

DG Innovate has lower revenue, but higher earnings than Shield Therapeutics.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Shield Therapeutics£21.47M1.09-£36.17M-£0.04-75.00
DG Innovate£24.50K327.86-£4.91MN/AN/A

11.9% of Shield Therapeutics shares are owned by institutional investors. Comparatively, 8.0% of DG Innovate shares are owned by institutional investors. 62.2% of Shield Therapeutics shares are owned by insiders. Comparatively, 45.7% of DG Innovate shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a stock is poised for long-term growth.

In the previous week, Shield Therapeutics had 2 more articles in the media than DG Innovate. MarketBeat recorded 2 mentions for Shield Therapeutics and 0 mentions for DG Innovate. Shield Therapeutics' average media sentiment score of 0.66 beat DG Innovate's score of 0.00 indicating that Shield Therapeutics is being referred to more favorably in the media.

Company Overall Sentiment
Shield Therapeutics Positive
DG Innovate Neutral

DG Innovate has a net margin of 0.00% compared to Shield Therapeutics' net margin of -168.42%. DG Innovate's return on equity of -129.16% beat Shield Therapeutics' return on equity.

Company Net Margins Return on Equity Return on Assets
Shield Therapeutics-168.42% -261.67% -47.85%
DG Innovate N/A -129.16%-50.26%

Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score
Shield Therapeutics
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A
DG Innovate
0 Sell rating(s)
0 Hold rating(s)
0 Buy rating(s)
0 Strong Buy rating(s)
N/A

Summary

Shield Therapeutics beats DG Innovate on 7 of the 13 factors compared between the two stocks.

Media Sentiment Over Time

This chart shows the average media sentiment of LON and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

DGI vs. The Competition

MetricDG InnovateElectrical Equipment & Parts IndustryIndustrials SectorLON Exchange
Market Cap£8.03M£1.57B£3.93B£1.58B
Dividend YieldN/A3.74%4.17%11.03%
P/E Ratio-1.25363.96527.281,730.79
Price / Sales327.862,119.64425.31229,524.84
Price / CashN/A19.6726.5235.78
Price / BookN/A3.513.632.87
Net Income-£4.91M-£43.33M£183.99M£144.63M
7 Day PerformanceN/A-0.88%0.08%0.11%
1 Month PerformanceN/A-2.66%0.00%-0.11%
1 Year PerformanceN/A20.66%29.71%15.22%

DG Innovate Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
DGI
DG Innovate
N/AGBX 0.07
+17.4%
N/A+115.4%£8.03M£24,500.00-1.25790Gap Down
High Trading Volume
STX
Shield Therapeutics
N/AGBX 3
+3.4%
N/A-51.5%£23.46M£21.47M-75.0040,000News Coverage
APC
Apc Technology Group
N/AGBX 9.88
flat
N/A+0.0%£18.03M£19.20M19.75164,000
STK
StreaksAI
N/AGBX 0.18
flat
N/AN/A£663,000.00N/A-32.503
IDEA
Ideagen
N/AGBX 349
-0.3%
N/A+0.0%£1.03B£75.28M17,450.009
ELX
El Oro
N/AGBX 65
flat
N/A+0.0%£41.06M£-7,248,605.00-26.001,122
GELN
Gelion
N/AGBX 19.50
flat
N/A-22.0%£26.52M£2.09M-325.0043Gap Down
DWHA
Dewhurst Group
N/AGBX 540
flat
N/A-4.4%£23.92M£58.55M857.14338
EAAS
eEnergy Group
2.8451 of 5 stars
GBX 5.40
-2.7%
GBX 12
+122.2%
+39.4%£20.91M£17.54M-7.30131News Coverage
Gap Down
PPS
Proton Motor Power Systems
N/AGBX 0.75
-21.1%
N/A-83.0%£12.45M£1.82M-75.00115Gap Up
High Trading Volume
LPA
LPA Group
N/AGBX 58
flat
N/A-29.3%£7.84M£24.14M828.57140News Coverage

Related Companies and Tools


This page (LON:DGI) was last updated on 11/2/2024 by MarketBeat.com Staff
From Our Partners